20260430_LIFE_Ringkasan Risalah//Risalah RUPS_32075807_lamp3.pdf

C. Providing the Opportunity to Ask Questions and/or Give Opinions Related to the
   Meeting Agenda
   In the Meeting, an opportunity has been given to ask questions and/or provide
   responses related to each Meeting Agenda, but none of the shareholders or proxies of
   shareholders have asked questions and/or provided responses related to the Meeting
   Agenda.

   During the question-and-answer session, there was one question from a shareholder
   and/or a shareholder’s representative who was present.

D. Meeting Decision-Making Mechanism
   Decision-making is carried out by voting orally and electronically (e-voting).


E. Results of the Meeting Decision-Making
   The results of the decision for all Meeting Agenda have been approved unanimously by
   deliberation for the consensus of all shareholders present or a total of 1.681.007.702
   shares (100% of the total of all shares valid and present at the Meeting).


F. Resolution of the GMS
   All matters discussed and decided in the Meeting are stated in the Deed of Meeting
   Minutes Number 73 dated April 28, 2026, made by Notary Aulia Taufani, S.H. which
   basically contains the following matters:

   Agenda of the First Meeting

   1. Approved the Company's Annual Report and the Board of Commissioners'
      Supervisory Task Report for the financial year ended December 31, 2025.

   2. Reaffirms the endorsement of the Company's Financial Statements for the
      financial year ended December 31, 2025 which has been audited by Public
      Accounting Firm Purwanto, Susanti & Surja, a member of Ernst & Young Global in
      accordance       with      the       Independent      Auditor's      Report     No.
      00384/2.1505/AU.1/08/1800-3/1/III/2026 dated March 30, 2026, with reasonable
      opinion in all material matters in accordance with Financial Accounting Standards in
      Indonesia.

   3. To provide full repayment and release of responsibility (acquit et de charge) to all
      members of the Company's Board of Directors for management actions and to all
      members of the Company's Board of Commissioners for supervisory actions that
      have been carried out during the financial year 2025, to the extent that such
      actions are reflected in the Company's Financial Statements for the financial year
      2025.

Second Agenda of the Meeting

1. Stipulates that in accordance with the Company's Financial Statements for the
   financial year ended December 31, 2025, which have been audited by the Public
   Accounting Firm of Purwanto, Susanti & Surja (a member of Ernst & Young Global),
   the Company's net profit is IDR 206,228,219,177 (Two Hundred Six Billion, Two
   Hundred Twenty-Eight Million, Two Hundred Nineteen Thousand, One Hundred
   Seventy Seven Rupiah) ("The Company's Net Profit 2025"), which includes the
   financial results of the Sharia business segment.

   Excluding the Sharia Business Segment taking into account general reserves of 1%
   (one percent), the Company's net profit is IDR 204,237,397,743 (Two Hundred Four
   Billion, Two Hundred Thirty-Seven Million, Three Hundred Ninety Seven Thousand,
   Seven Hundred Forty-Three Rupiah) ("The Company's Net Profit").

2. Set the use of Profit as follows:
    a) In the amount of Rp1,990,821,434 (One Billion, Nine Hundred and Ninety
        Million, Eight Hundred and Twenty-One Thousand, Four Hundred and Thirty-
        Four Rupiah) of the remaining Net Profit 2025 that has not been distributed
        and has not been determined for use as an additional General Reserve of the
        Company; and

   b)   An amount of IDR 201,600,000,000 (Two Hundred One Billion Six Hundred
        Million Rupiah) or IDR 96 per share) derived from Net Profit in 2025 excluding
        the Sharia Business Segment and the accumulated remaining profit of the
        previous year will be distributed as cash dividends to Shareholders. The
        amount of cash dividends is equivalent to 99% of the Net Profit in 2025
        excluding the Sharia Business Segment.

   c)   The following terms and conditions apply to the payment of cash dividends:
        i. Cash dividends for the financial year 2025 will be paid for each share issued
           by the Company that is recorded in the Company's Register of Shareholders
           on the recording date to be determined by the Board of Directors;

        ii. For the payment of cash dividends for the 2025 financial year, the Board of
            Directors is authorized with the right of substitution to withhold dividend
            tax in accordance with applicable tax regulations;

        iii. The Board of Directors is empowered with the right of substitution to
             determine matters related to the implementation of cash dividend
             payments for the financial year 2025, including but not limited to
             determining the schedule and procedures for the distribution of cash
             dividends by taking into account the provisions stipulated in the regulations
             of the Financial Services Authority, the regulations of the Indonesia Stock
             Exchange, and other related laws and regulations, and subsequently submit
             reports and/or request approval from the parties the authority, as well as
             taking any and all necessary actions in connection with the distribution of
             such cash dividends in accordance with the applicable laws and regulations.

   3. Dividend Distribution Schedule
       No                     Remarks                          Date
        1 Report on the Distribution of Cash
                                                          April 30, 2026
            Dividends to the Indonesia Stock Exchange
        2 Announcement          of    Cash     Dividend
                                                          April 30, 2026
            Distribution
        3 Cum Dividend Dates in the Regular and
                                                          May 7, 2026
            Negotiated Markets
        4 Ex Dividend Date in the Regular and
            Negotiated Market                             May 8, 2026
        5 Cum Dividend Date in the Cash Market            11 May 2026
        6 Ex Dividend Date in the Cash Market             12 May 2026
        7 Date of Registration of Shareholders
                                                          11 May 2026
            entitled to Cash Dividend (Recording Date)
        8 Cash Dividend Payment Date for Fiscal Year
                                                          28 May 2026
            2025


Third Agenda of the Meeting

1. Authorize the Board of Commissioners on the proposal of the Nomination and
   Remuneration Committee to determine salaries, allowances, and/or bonuses to the
   members of the Company's Board of Directors for the financial year 2026 taking
   into account the Company's financial condition.

2. Authorize the Board of Commissioners on the proposal of the Nomination and
   Remuneration Committee to determine salaries or honorariums, allowances,
   and/or bonuses to the members of the Company's Board of Commissioners for the
   financial year 2026 taking into account the Company's financial condition.

Fourth Agenda of the Meeting

1. Approved to authorize the Board of Commissioners to appoint an Independent
   Public Accountant from an Independent Public Accounting Firm registered with the
   Financial Services Authority in connection with the selection process of a Public
   Accountant to audit the Company's Financial Statements for the financial year
   ended December 31, 2026, which is still ongoing with the following criteria: Public
   Accountants and Public Accounting Firms are required to be registered with the
   Financial Services Authority, and are independent and professional parties to audit
   the Company's Financial Statements ended December 31, 2026, taking into account
   the recommendations of the Audit Committee.

2. Approved to authorize the Board of Commissioners to determine the amount of
   honorarium and other requirements in connection with the appointment of such
   Public Accountant/Public Accounting Firm in accordance with applicable provisions.

   Agenda of the Fifth Meeting

   1. Approved the appointment of new members of the Board of Directors and Board
      of Commissioners of the Company, effective from the time it is declared to have
      passed the Feasibility and Propriety Test by the OJK until the close of the second
      (2nd) Annual GMS held in 2028, with the following arrangement:
      a) Mrs. Nazly Parlindungan Siregar as Independent Commissioner
      b) Mr. Wianto as President Director
      c) Mr. Ken Terada as Director

   2. Henceforth, the composition of the Board of Commissioners, Board of Directors
      and the Company's Sharia Supervisory Board since the closing of the Meeting is as
      follows:

       Board of Commissioners
       President Commissioner               : Indra: Widjaja
       Commissioner                         : Hideaki
                                                   : Nomura
       Commissioner                         : Kimitake
                                                   :    Sugiura
       Independent Commissioner             : Sidharta
                                                   :   Akmam
       Independent Commissioner             : Nazly: Parlindungan Siregar
       Independent Commissioner             : Teuku: Radja Sjahnan

       Board of Directors
       President Director                   : Wianto:
       Deputy President Director            : Tomoyuki
                                                    :    Monden
       Director                             : Herman: Sulistyo
       Director                             : Ken Terada
                                                    :
       Director                             : Eiji Takahashi
                                                    :
       Director                             : Elly Susanti
                                                    :

       Sharia Supervisory Board
       Chairman                             : Dr. H. Rahmat Hidayat, SE, MT
       Members                              : Ahmadi Sukarno


   4. Granting power of attorney with the right of substitution to the Company's Board
      of Directors to restate all or part of the decision of the Meeting in a notary deed
      and subsequently notify the composition of the Company's Management to the
      Ministry of Law of the Republic of Indonesia and other agencies, as well as take all
      necessary actions in accordance with the provisions of the applicable laws and
      regulations.


This summary of the minutes of the Meeting is also available and can be accessed on the
Company's official website (www.msiglife.co.id


                                 Jakarta, April 30, 2026

                        PT MSIG Life Insurance Indonesia Tbk
                                 Board of Directors